allosteric AMPA receptor modulators (University of Sussex/Wellcome Trust/GlaxoSmithKline)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameallosteric AMPA receptor modulators (University of Sussex/Wellcome Trust/GlaxoSmithKline)
Drug Alias NameAMPA receptor modulators (University of Sussex/Wellcome Trust/GlaxoSmithKline)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate receptor ionotropic AMPA agonists
TargetsGlutamate receptor ionotropic AMPA
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Sussex
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of SussexGlaxosmithkline PlcWellcome Trust
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A